Independent French researchers discovered a significant increase in newborn deaths in France coinciding with the rollout of Beyfortus, a new respiratory syncytial virus shot for infants. French researchers identified possible safety signals in babies coinciding with the rollout of Beyfortus, a recently approved monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns. The discovery…